Major changes have taken place within the last few years in the management of follicular
lymphoma (FL) leading to substantial improvement in prognosis and overall survival. For …

Disease overview Follicular lymphoma is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by …

The role of autologous stem cell transplantation (ASCT) and the optimal timing of such
transplants in patients with follicular lymphoma (FL) remains contentious. We present a …

Background The aim of this study was to investigate the impact of the high-dose regimen on
the outcome of patients with follicular lymphoma (FL) having had autologous stem-cell …

Hypermethylation of DAPK1 promoter gene was found to be a frequent epigenetic alteration
in follicular lymphoma (FL). We evaluated whether the quantification of DAPK1 methylation …

Follicular lymphoma (FL) is the most common indolent non-Hodgkin's lymphoma in northern
America. FL is an incurable disease with relapsing–remitting courses requiring serial …

Autologous hematopoietic stem cell transplantation (AHSCT) is a treatment option for
relapsed and recurrent follicular lymphoma (R/R FL); however, its value in the rituximab era …

The prognosis of follicular lymphoma (FL) has significantly improved over the last decade,
particularly following the introduction of the anti-CD20 monoclonal antibody rituximab, which …

Follicular lymphoma (FL) is the second most frequent type of lymphoma subtype worldwide,
with a rising incidence particularly in Western countries1, 2). It represents approximately 30 …

This chapter presents a series of questions and answers on hematopoietic cell
transplantation in indolent non‐Hodgkin's lymphoma. It commences with a discourse on the …